Nexo Therapeutics

About:

Nexo Therapeutics offers treatments for some of cancer's most intractable targets.

Top Investors: New Enterprise Associates, Cormorant Asset Management, Versant Ventures

Description:

Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.

Total Funding Amount:

$60M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Littleton, Colorado, United States

Founded Date:

2022-01-01

Contact Email:

info(AT)nexotx.com

Founders:

Andrew Phillips, John Athanasopoulos, Michael Kim, Rhamy Zeid

Number of Employees:

11-50

Last Funding Date:

2023-07-26

IPO Status:

Private

Industries: